Concepedia

David Flowers

DF

31

Publications

4.2K

Citations

21

H-Index

1984

Active since

Affiliations

Fred Hutch Cancer Center(Current)

Albert Einstein College of Medicine

University of Washington

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Cancer Research Center

David Flowers is an author at Fred Hutch Cancer Center specializing in medicine, pharmacotherapy, and cardiology.

ORCID

Top concepts

Publications per year

1984–2024

31

Publications

31

Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling

Barbara Varnum‐Finney, Lanwei Xu, Carolyn Brashem‐Stein et al. · Nature Medicine · 2000 · 634 citations

, , +10

Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

Philip R. Hamann, Lois M. Hinman, Irwin Hollander et al. · Bioconjugate Chemistry · 2001 · 582 citations

, , +16

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, F R Appelbaum, Ricardo Spielberger et al. · Blood · 1999 · 456 citations

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, Frederick R. Appelbaum, Ricardo Spielberger et al. · Blood · 1999 · 437 citations

The Notch Ligand, Jagged-1, Influences the Development of Primitive Hematopoietic Precursor Cells

Barbara Varnum‐Finney, Louise E. Purton, Monica Yu et al. · Blood · 1998 · 325 citations

Rows per page

1–5 of 31